Entact Bio
PrivateLast Round
Seed Round
Jun 3, 2026
Total Funding Raised
$121.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Entact Bio is a biotechnology company that develops small-molecule drugs called ENTACs to enhance the function of beneficial proteins through natural cellular mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Entact Bio Comparables
Compare Entact Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stablix | 86% | |
| Vicinitas Therapeutics | 82% | |
| Outrun Therapeutics | 77% |
Entact Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2026 | ||||
| Series A Extension | Jan 17, 2024 | ||||
| Series A | Dec 6, 2022 | ||||
| Seed | Oct 1, 2019 |
Key People
Founding team and executive leadership
Entact Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A |
| Janus Henderson Group | Series A |
| 4BIO Capital | Series A, Seed |
| Logos Capital | Series A |
| Abingworth | Series A |
| Arkin Holdings | Series A |
| Citadel | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$10M raised in Seed Round.
- Dec 6, 2022
$81M round led by Qiming
Entact Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Entact Bio's valuation, stock price, and market status.
Is Entact Bio a public or private company?
Entact Bio is a private company.
What is the current stock price of Entact Bio?
Entact Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Entact Bio worth (valuation)?
Valuation information for Entact Bio is not publicly available.
Can I buy Entact Bio stock?
Entact Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Entact Bio's last funding round?
Entact Bio's most recent funding round was Seed Round on June 3, 2026.
Who are the main investors in Entact Bio?
Key investors in Entact Bio include Qiming.
Will Entact Bio IPO soon?
No public IPO plans have been announced for Entact Bio.
How can I track Entact Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Entact Bio's secondary market activity and sign up for updates.